Non Invasive Blood Glucose Monitoring System Market

Key Segments Analysis

By Technology

• Spectroscopy
• Optical Sensors
• Electromagnetic Field-Based Sensors
• Biosensors
• Thermal Sensors
• Ultrasonic Sensors
• Others

By Modality

• Non wearable
• Wearable

By End-User

• Hospitals
• Homecare
• Clinics

Market Dynamics

Increasing Prevalence of Diabetes

Changing lifestyles and unhealthy dietary habits have contributed significantly to the rising prevalence of diabetes. In today’s fast-paced world, many individuals have limited time for cooking and often rely on convenient, packaged, and processed foods. These foods are often high in refined sugars, unhealthy fats, and calories, and lack essential nutrients.

Additionally, they tend to have high sodium content, which can contribute to hypertension and other risk factors for diabetes. These rising rates of patients with diabetes highlight the urgent need for effective diabetes management solutions, including advanced technologies like continuous glucose monitors, to address the growing health challenge posed by this chronic condition.

• For instance, approximately 537 million adults (20-79 years) were living with diabetes in 2021. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. Further, 3 in 4 adults with diabetes live in low- and middle-income countries. According to the International Diabetes Federation (IDF), the global prevalence rate of diabetes stands at 6.1%, ranking it among the top 10 causes of death and disability worldwide. At the super-region level, North Africa and the Middle East have the highest prevalence rate at 9.3%, with projections indicating a rise to 16.8% by 2050. Similarly, in Latin America and the Caribbean, the diabetes rate is expected to increase to 11.3% in the coming years.

Market Restraints

Patient Skepticism toward Non-Invasive Technologies

Patient skepticism remains a significant barrier to the widespread adoption of non-invasive blood glucose monitoring systems. Although non-invasive methods offer clear benefits, such as eliminating the need for frequent finger pricks and providing a more comfortable experience, many patients remain hesitant to switch from traditional invasive techniques.

This skepticism often stems from concerns about the accuracy and reliability of newer, non-invasive devices, especially when compared to the proven performance of conventional methods like fingerstick glucose tests and continuous glucose monitors (CGMs) that require skin penetration. Furthermore, a lack of awareness and education about the capabilities of newer non-invasive glucose monitors exacerbates this issue.

While the technology has progressed, there is a communication gap in educating patients on the benefits and accuracy improvements of these devices. Many patients continue to rely on traditional methods simply because they are more familiar and trusted, even if non-invasive alternatives could offer them more convenience and comfort. Additionally, older patients, who represent a significant portion of the diabetes population, may be less inclined to adopt new technologies due to unfamiliarity or a lack of confidence in their use.

• Low level of wearable use (17.49%) among the US older adults was found during a study published by Health Informatics Journal, in November 2021.

Market Opportunities

Enhanced Market Growth through Increased Regulatory Approvals

The non-invasive blood glucose monitoring market is experiencing significant growth opportunities through increased regulatory approvals, which are essential for introducing innovative technologies to healthcare markets worldwide. Such approvals not only validate the safety and efficacy of new devices but also broaden their accessibility to patients and healthcare providers, driving market expansion and technological adoption.

These agencies assess medical devices to ensure they meet stringent safety and performance criteria before granting approval for commercial use. Once approved, these technologies can reach a broader patient base, offering more individuals access to convenient and less painful glucose monitoring options.

• For example, in March 2024, the FDA approved the Dexcom Stelo Glucose Biosensor System, a landmark event as it marked the first over-the-counter (OTC) continuous glucose monitor (CGM) cleared for the general population aged 18 and older who do not use insulin. This system is designed for individuals managing their diabetes with oral medications and those without diabetes who wish to monitor how their lifestyle affects their blood sugar levels. This approval is particularly noteworthy because it expands the use of CGM systems beyond the traditional prescription model, making it available directly to consumers without the need for a doctor’s prescription.

Impact of macroeconomic factors / Geopolitical factors

Macroeconomic and geopolitical factors play a significant role in shaping the non-invasive blood glucose monitoring system market. Economic conditions, such as GDP growth and healthcare spending, influence the adoption of advanced healthcare technologies, with higher disposable incomes leading to increased demand for innovative diabetic care solutions like NIBGM systems.

During economic downturns, however, consumers and healthcare providers may prioritize cost-effective options, potentially slowing market growth. Geopolitical factors, including international trade relations, regulatory policies, and political stability, can affect the availability of materials, manufacturing, and distribution channels for these systems. Trade barriers or tariffs may increase production costs, impacting affordability and accessibility.

Latest Trends

The non-invasive blood glucose monitoring system market is experiencing notable trends driven by technological advancements and increasing diabetes prevalence. One key trend is the rise of wearable devices, such as smartwatches and patches, that continuously monitor glucose levels without the need for traditional blood samples. This trend is fuelled by advancements in sensors, biosensors, and optical technologies, allowing for more accurate, real-time readings.

Additionally, there is growing interest in non-invasive monitoring solutions due to the increasing demand for pain-free and convenient alternatives to finger-prick tests. Moreover, the integration of artificial intelligence (AI) and machine learning (ML) with NIBGM devices is enhancing predictive analytics, helping users manage glucose levels more effectively.

The expanding adoption of these systems is further supported by rising health awareness, the aging population, and increasing healthcare expenditures. As a result, the NIBGM market is seeing rapid innovation and increasing investment, positioning it for significant growth.

Regional Analysis

The North America non-invasive blood glucose monitoring system market is experiencing growth due to the rising number of diabetes patients in the region. As the prevalence of diabetes continues to increase, there is a growing demand for non-invasive blood glucose monitoring systems that offer convenience and improved patient compliance. These non-invasive monitoring systems eliminate the need for traditional finger-prick testing, providing a more comfortable and less intrusive method for diabetes management.

• For instance, according to the 2022 data published by the American Diabetes Association (ADA), it was reported that more than 10 million Americans are treated with insulin and receive positive results from a continuous glucose monitoring (CGM) system. The penetration is likely to increase in the country in the coming years owing to the growing prevalence of diabetes along with an increasing shift of preference among the patient population toward CGMs for monitoring diabetes.

Non-Invasive Blood Glucose Monitoring System Market, Regional Analysis, 2020-2024 (US$ Million)